Invesaro

Stocks Comparison

CONMED vs Integer: revenue, profit, margins and growth compared

CONMED brought in $1.4B of revenue in fiscal 2025, Integer $1.9B in fiscal 2025. Revenue changed by +5.2% at CONMED and +8.0% at Integer on the year before, so Integer grew faster. CONMED kept 3.4% of its revenue as net profit, Integer 5.5%. Free cash flow was $150.9M at CONMED and $105.1M at Integer.

Side by side, latest fiscal year

CNMDITGR
Fiscal year endedFY2025 (December 31, 2025)FY2025 (December 31, 2025)
Revenue$1.4B$1.9B
Revenue growth+5.2%+8.0%
Net income$47.1M$102.8M
Net margin3.4%5.5%
Free cash flow$150.9M$105.1M
Free cash flow margin11.0%5.7%
Earnings per share (diluted)$1.51$2.89
Cash$40.8M$17.2M
Debt$834.9M$1.2B
Price to earnings30.143.7
Market value$1.4B$4.3B
Dividend yield1.32%n/a
Rank by revenue in sector#131 of 523 · Health care#114 of 523 · Health care

Over the years

Revenue
CNMD FY2018: $859.6MCNMD FY2019: $955.1MCNMD FY2020: $862.5MCNMD FY2021: $1BCNMD FY2022: $1BCNMD FY2023: $1.2BCNMD FY2024: $1.3BCNMD FY2025: $1.4BITGR FY2018: $1.2BITGR FY2019: $1.3BITGR FY2020: $1.1BITGR FY2021: $1.2BITGR FY2022: $1.3BITGR FY2023: $1.6BITGR FY2024: $1.7BITGR FY2025: $1.9BFY18FY19FY20FY21FY22FY23FY24FY25
CNMD $1.4BITGR $1.9B
Net income
CNMD FY2018: $40.9MCNMD FY2019: $28.6MCNMD FY2020: $9.5MCNMD FY2021: $62.5MCNMD FY2022: -$80.6MCNMD FY2023: $64.5MCNMD FY2024: $132.4MCNMD FY2025: $47.1MITGR FY2018: $168MITGR FY2019: $96.3MITGR FY2020: $77.3MITGR FY2021: $96.8MITGR FY2022: $66.4MITGR FY2023: $90.7MITGR FY2024: $119.9MITGR FY2025: $102.8MFY18FY19FY20FY21FY22FY23FY24FY25
CNMD $47.1MITGR $102.8M
Net margin
CNMD FY2018: 4.8%CNMD FY2019: 3.0%CNMD FY2020: 1.1%CNMD FY2021: 6.2%CNMD FY2022: -7.7%CNMD FY2023: 5.2%CNMD FY2024: 10.1%CNMD FY2025: 3.4%ITGR FY2018: 13.8%ITGR FY2019: 7.7%ITGR FY2020: 7.2%ITGR FY2021: 7.9%ITGR FY2022: 5.0%ITGR FY2023: 5.8%ITGR FY2024: 7.0%ITGR FY2025: 5.5%FY18FY19FY20FY21FY22FY23FY24FY25
CNMD 3.4%ITGR 5.5%
Revenue growth
CNMD FY2019: +11.1%CNMD FY2020: -9.7%CNMD FY2021: +17.2%CNMD FY2022: +3.4%CNMD FY2023: +19.1%CNMD FY2024: +5.0%CNMD FY2025: +5.2%ITGR FY2019: +3.5%ITGR FY2020: -14.7%ITGR FY2021: +13.8%ITGR FY2022: +9.0%ITGR FY2023: +16.9%ITGR FY2024: +10.3%ITGR FY2025: +8.0%FY19FY20FY21FY22FY23FY24FY25
CNMD +5.2%ITGR +8.0%
Free cash flow
CNMD FY2018: $58.2MCNMD FY2019: $75.1MCNMD FY2020: $51.5MCNMD FY2021: $96.9MCNMD FY2022: $11.6MCNMD FY2023: $106.3MCNMD FY2024: $153.9MCNMD FY2025: $150.9MITGR FY2018: $122.4MITGR FY2019: $117.2MITGR FY2020: $134.5MITGR FY2021: $103.2MITGR FY2022: $41.7MITGR FY2023: $60.3MITGR FY2024: $99.8MITGR FY2025: $105.1MFY18FY19FY20FY21FY22FY23FY24FY25
CNMD $150.9MITGR $105.1M

Fiscal years as each company reports them; the two may end in different months.

Questions about CONMED and Integer

Which is bigger by revenue, CONMED or Integer?

Integer is bigger by revenue: $1.9B in fiscal 2025, against $1.4B for CONMED in fiscal 2025.

Which keeps more of its revenue as profit, CONMED or Integer?

CONMED had a net margin of 3.4% in fiscal 2025; Integer had 5.5% in fiscal 2025.

Which grew revenue faster, CONMED or Integer?

In their latest fiscal years revenue changed by +5.2% at CONMED and +8.0% at Integer.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies